London, UK – 9th September 2009 - Cisiv (www.cisiv.com), a specialist provider of services and technologies that  help pharmaceutical companies capture real world patient data, has been shortlisted for the Clinical Research Excellence Awards 2009 in the category of Best Technological Development in Clinical Trials - Software Solutions. The Awards, run by Good Clinical Practice Journal, showcase the biggest achievements and innovations in international clinical trial technology, best practice and study design.

With Baseline Plus, pharmaceutical organisations benefit from faster delivery of information for patient safety and health economic purposes, while investigators can get access to information on conditions and treatments that they are interested in. Baseline Plus is web-based and intuitive to use, making it simple to roll out across large numbers of investigators globally while also reducing the amount of time needed to train users.

Cisiv’s Baseline Plus solution is used by trial sponsors and investigators to capture real world patient data during non-interventional studies. These studies can cover hundreds of sites and multiple countries; consequently, Cisiv has developed its unique electronic data capture solution in response to the growing importance of non-interventional studies where simplicity and ease of use are critical cost-saving features.

Dominic Farmer, CEO at Cisiv, commented, “We are very proud to have been included in such a prestigious set of awards. Being shortlisted for the GCPj Clinical Research Excellence Awards is a validation of the work that our customers are doing around post-approval trials, as well as our approach to supporting non-interventional studies in a way that is very different to traditional clinical trials.”

The Clinical Research Excellence Awards will be presented at a gala dinner event on the 20^th of October 2009. More information on the Awards can be found at www.gcpjawards.com

Cisiv provides technology platforms and consulting services to pharmaceutical companies, enabling them to understand how their products and treatments are being used in real world settings. A specialist in large-scale non-interventional studies, the company’s next generation web-based software platform allows patient data to be easily captured, analysed and shared. 

 

With new levels of intelligence harnessed using Cisiv’s platform, pharmaceutical decision-makers can demonstrate the effectiveness of treatments and identify additional patient value and healthcare benefits way beyond what can be achieved through traditional study methods.

 

Cisiv’s clients include Johnson & Johnson, Pfizer and the Institute of Cancer Research. Cisiv is a privately held company headquartered in London. For further information please see www.cisiv.com.

 

Mark Kember/Kellie Collier

Goode International

Tel: + 44 (0)1491 873 323

Email: mark.kember@goode.co.uk / kellie.collier@goode.co.uk

 

Christopher Keeling

Good Clinical Practice Journal

Tel: +44 (0)20 3377 3183

Email: Christopher.Keeling@Informa.com